Takeda Offers To Sell Shire Drug To Get EU's OK For Takeover
By Matt Bernardini ( October 29, 2018, 6:27 PM EDT) -- Japanese pharmaceutical giant Takeda announced Monday that it has proposed selling a drug used to treat inflammatory bowel diseases that it would gain in its £46 billion ($60 billion) acquisition of Dublin's Shire to satisfy European regulators' competition concerns....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.